Skip 
Navigation Link
Addictions
Resources
Basic Information
What is Addiction?What Causes Addiction?How Do You Get Addicted?Signs and Symptoms of AddictionTreatment for AddictionReferencesResourcesFrequentlly Asked Questions about Addiction
TestsLatest News
Health Tip: Recovering From Substance AbuseMedicare Could Do More to Stem Opioid EpidemicNew Online Tool Aids Search for Alcohol TreatmentHeroin Taking Bigger Share of U.S. Opioid ODsRapid Test for Meth Abuse May Be NearPost-Op Opioids: How Much Is Enough?CDC Launches Opioid Campaign in Hard-Hit StatesERs Prescribing Opioids at Lower Doses, Shorter DurationsAddictive Opioids Common for People on DialysisBooze Often Glorified On YouTube VideosOpioid ODs Have Cut Into U.S. Life Expectancy: CDCAAP: Opioid Dependence/Abuse Public Health Issue for ChildrenSurgery Can Be Trigger for Teen Opioid AbuseFDA Permits Marketing of App to Help Treat Substance AbuseApp to Help Treat Substance Abuse ApprovedFentanyl Drives Rise in Opioid-Linked Deaths in U.S.Opioid Overdoses and Deaths Flooding U.S. HospitalsIncrease in Alcohol Use, High-Risk Drinking in U.S. AdultsAlcohol Use, Abuse on the Rise in U.S.U.S. Opioid Crisis Continues to Worsen'12-Step' Strategy Boosts Success of Teen Drug Abuse ProgramAddiction Drug Underused by Primary Care Docs in U.S.7-Fold Spike Seen in Opioid-Linked Fatal Car CrashesNew Alcohol Screening, Brief Intervention Manual DevelopedOpioid Abuse Down in Younger Americans, But Up Among Older AdultsTreating ADHD May Help Curb Later Drinking, Drug ProblemsNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemCan Fetal Alcohol Damage Be Undone?Hospitalists Have Role to Play in Mitigating Opioid Use DisorderOpioids Second Only to Marijuana in Illicit Drug Abuse RatesEnding U.S. Opioid Abuse Epidemic Will Take Years: ReportMore Research Shows Big Surge in U.S. Opioid Use, AddictionsOpioid Addicts Find It Hard to Avoid FentanylAddicts Try to Avoid Deadly Fentanyl, But Many Tragically FailPot Plus Booze: A Deadly Mix Behind the WheelAs U.S. Heroin Use Reaches 20-Year High, Cost to Society SoarsHeroin Vaccine Blocks Drug High in Tests on MonkeysElite High Schools Breed Higher Risk of Addiction: StudyDid a 1980 Letter Help Spark the U.S. Opioid Crisis?1 in 4 Americans Knows Someone Hooked on Opioids: PollIt's Often Family to the Rescue During Opioid ODsGuidelines Issued on Substance Use Disorder Treatment in NursesDrug-Impaired Driving Continuing to Rise in the United StatesDrugs Now Involved in More Fatal U.S. Crashes Than Alcohol AloneClinician Awareness of Exercise Addiction May Be LackingHigher Illicit Pot Use in States That OK Medical Marijuana: StudyTrump Administration Offers Grants to Fight Opioid CrisisOpioid Abusers at Higher Death Risk When Addiction Specialists Not Part of CareMany Opioid Addictions Surface After Surgery, Study FindsRehab Services Lacking in States Hit Hard by Opioids
LinksBook ReviewsSelf-Help Groups
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Post-Traumatic Stress Disorder

Naloxone Price Hikes Could Affect Rates of Opioid-Related Deaths


HealthDay News
Updated: Dec 8th 2016

new article illustration

THURSDAY, Dec. 8, 2016 (HealthDay News) -- Escalating prices of the drug naloxone may threaten efforts to reduce opioid-related deaths across America, according to a perspective piece published in the Dec. 8 issue of the New England Journal of Medicine.

The research team from Yale University and the Mayo Clinic called attention to the increasing prices, noting that (1) Hospira (a Pfizer company) charges $142 for a 10-pack of naloxone -- up 129 percent since 2012; (2) Amphastar's 1 mg version of naloxone is used off-label as a nasal spray. It's priced around $40 -- a 95 percent increase since September 2014; and (3) newer, easier-to-use formulations are even more expensive -- a two-dose package of Evzio (naloxone) costs $4,500, an increase of more than 500 percent over two years.

Naloxone is part of a wave of precipitous price hikes affecting old and new medicines. These drugs include Mylan's EpiPen injectors for life-threatening allergic reactions; Turing Pharmaceuticals' Sovaldi for hepatitis C; and insulin for diabetes made by Eli Lilly and Company, Novo Nordisk, and Sanofi U.S.

Several U.S. agencies have recommended boosting access to naloxone to combat prescription opioid-related deaths, the study authors noted. The authors argued that the government should do more to ensure the drug is affordable. Possible strategies include: encouraging generic competition; buying in bulk; and importing generics from international manufacturers. The government could also invoke a federal law that allows it to contract with a manufacturer to produce less-costly versions, the study authors suggested. It's also possible that the U.S. Food and Drug Administration could switch naloxone to over-the-counter status, the researchers said.

Full Text